{"components": [{"mw": "561.72", "idout": "ACEBOD", "name": "3-methyl-1-tetradecyl-2-(thiazol-4-yl)benzimidazolium trifluoromethanesulfonate", "formula": "C<SUB>26</SUB>H<SUB>38</SUB>F<SUB>3</SUB>N<SUB>3</SUB>O<SUB>3</SUB>S<SUB>2</SUB>", "sample": [["Source:", "synthesized by the authors"], ["Purification:", "estimated by the compiler"], ["Purity:", "98 mass %(crystallization from solution;dried by vacuum heating)"]]}], "title": "Phase transition properties: Normal melting temperature", "dhead": [["Normal melting temperature, K"]], "data": [[["328.1", "2"]]], "solvent": null, "footer": "", "expmeth": "Visual observation", "constr": ["Pressure of 1 atm"], "ref": {"full": "El Bourakadi, K.; Merghoub, N.; Hicham, G.; Mekhzoum, M. E. M.; Essassi, E. M.; Qaiss, A. e. k.; Bouhfid, R. (2019) J. Mol. Liq. 282, 63-69.", "title": "Synthesis, characterization and in vitro antiproliferative evaluation of ionic liquids based on alkyl-substituted thiabendazolium"}, "phases": ["Crystal", "Liquid"]}